Venetoclax resistance and acquired mutations in chronic lymphocytic leukemia

Tools

Item Type:	Editorial
Title:	Venetoclax resistance and acquired mutations in chronic lymphocytic leukemia
Creators Name:	Tausch, E., Close, W., Dolnik, A., Bloehdorn, J., Chyla, B., Bullinger, L., Döhner, H., Mertens, D. and Stilgenbauer, S.
Keywords:	Antineoplastic Agents, B-Cell Chronic Lymphocytic Leukemia, Disease Progression, Heterocyclic Bridged Bicyclo Compounds, High-Throughput Nucleotide Sequencing, Local Neoplasm Recurrence, Mutation, Neoplasm Drug Resistance, Phase II Clinical Trials, Proto-Oncogene Proteins c-bcl-2, Residual Neoplasm, Risk, Sulfonamides
Source:	Haematologica
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Volume:	104
Number:	9
Page Range:	e434-e437
Date:	September 2019
Official Publication:	https://doi.org/10.3324/haematol.2019.222588
External Fulltext:	View full text on PubMed Central
PubMed:	View item in PubMed

Repository Staff Only: item control page